Clinical trials recruiting for Clear Cell Renal Cell Carcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| MDNA11 | 1 |
| MGC026 Dose Escalation | 1 |
| MGC026 Dose for Expansion | 1 |
| NN3201 | 1 |
| Pembrolizumab (KEYTRUDA®) | 1 |
| XmAb819 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 3 |
| Michigan | 3 |
| Texas | 3 |
| Florida | 2 |
| Georgia | 2 |
| New York | 2 |
| Ohio | 2 |
| Oregon | 2 |
| Arizona | 1 |
| Connecticut | 1 |
| Illinois | 1 |
| Kentucky | 1 |
Top cities
Self-screener
Recruiting trials
- A Beta-only IL-2 ImmunoTherapY Study
- A Study of MGC026 in Participants With Advanced Solid Tumors
- A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Related conditions
Trials recruiting for Clear Cell Renal Cell Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Clear Cell Renal Cell Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.